A Trial Evaluating the Safety and Immunogenicity of 3 COVID-19 SARS-CoV-2 RNA Vaccines in Healthy Adults
Clinical trial NCT05037097 · COMPLETED
Trial details
- NCT number
- NCT05037097
- Sponsor
- Arcturus Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-30
- Primary completion
- 2023-12-19
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.